InsidersTradesSigma
Browse the detailed record of transactions filed by Lefkowitz Robert J Md, 董事. Director active across 1 company, notably Lexicon Pharmaceuticals, INC.. Cumulatively, 1 reports have been logged. History available since 30 April 2022. The latest transaction was disclosed on 30 April 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Robert J. Lefkowitz, MD, is a Board Member at Lexicon Pharmaceuticals, Inc. He brings medical and scientific expertise to the board, contributing to informed decision-making regarding product development and research strategies.